$10.46 Billion in Sales Expected for AstraZeneca PLC (NYSE:AZN) This Quarter

Brokerages expect that AstraZeneca PLC (NYSE:AZN – Get Rating) will report sales of $10.46 billion for the current quarter, according to Zacks. Two analysts have provided estimates for AstraZeneca’s earnings, with the lowest sales estimate coming in at $10.24 billion and the highest estimate coming in at $10.68 billion. AstraZeneca posted sales of $8.22 billion […]

Related Keywords

Tudorza Eklira Bretaris ,Farxiga Forxiga ,Bydureon Byetta ,Andexxa Ondexxya ,Duaklir Genuair ,Daliresp Daxas ,Brilinta Brilique ,Astrazeneca ,Zacks Investment Research ,Get Rating ,Investment Research ,Bevespi Aerosphere ,Breztri Aerosphere ,Nyse Azn ,Azn ,Manufacturing ,Ratings ,Consensus ,